By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. The company operates through the segment being Developing and commercializing proprietary therapeutics.

Contact Information

Website: www.zailaboratory.com
Email: billy.cho@zailaboratory.com
Main Phone: +86 2161632588
Address: 4560 Jinke Road
Address 2: Jinchuang Plaza, Building 1, 4th Floor
City / Town: Shanghai
Country: CN
Postal Code: 201210

Issuer Information

Exchange: NSD
CEO: Ying Du
Employees: 1194

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A